CPS1 and metabolic dysfunction-associated steatotic liver disease: In addition, both in rat model [42] and human cases [43] of NAFLD demonstrate the markedly reduction of CPS-1 and OTC activities (gene and protein expressions) leading to the impairment of urea synthesis.